Peutz-Jeghers syndrome screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Peutz-Jeghers syndrome}} | {{Peutz-Jeghers syndrome}} | ||
{{CMG}} | {{CMG}} {{AE}} {{MJK}} | ||
==Overview== | ==Overview== | ||
Screening for cancerous lesions by small intestine radiography, esophagogastroduodenoscopy, colonoscopy, pancreatic ultrasound, pelvic ultrasound, [[mammography]], and Papanicolaou (Pap) test | Screening for cancerous lesions by small intestine radiography, [[esophagogastroduodenoscopy]] (EGD), colonoscopy, pancreatic ultrasound, pelvic ultrasound, [[mammography]], and Papanicolaou (Pap) test are recommended among patients with Peutz-Jeghers syndrome. | ||
==Screening== | ==Screening== | ||
Patients who are at risk of developing Peutz-Jeghers syndrome are screened for the locations of the [[hamartomas]] by: | |||
*[[Esophagogastroduodenoscopy|upper GI endoscopy]] | |||
*[[Enteroclysis]] | |||
*[[Colonoscopy]] | |||
Screening for cancerous lesions include the following: | |||
*Small intestine radiography (every 2 years) | |||
*[[Esophagogastroduodenoscopy]] (every 2 years) | |||
*[[Colonoscopy]] every 2 years | |||
*Pancreatic ultrasound (annually) | |||
*[[Endoscopic ultrasound]] | |||
*[[Magnetic resonance cholangiopancreatography]] (MRCP) | |||
*Abdominal CT | |||
*Pelvic ultrasound (annually) | |||
*Testicular ultrasound (annually) | |||
*[[Mammography]] at ages 25, 30, 35, and 38 years, then every 2 years until age 50 years, then annually | |||
*Cervical Papanicolaou (Pap) test (annually). | |||
*Annual physical examination that includes evaluation of the breasts, abdomen, pelvis, and testes should be done by a physician | |||
*Annual complete blood count to check for anemia should be done | |||
== References == | == References == | ||
| Line 31: | Line 40: | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Syndromes]] | [[Category:Syndromes]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 18:51, 9 September 2015
|
Peutz-Jeghers syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Peutz-Jeghers syndrome screening On the Web |
|
American Roentgen Ray Society Images of Peutz-Jeghers syndrome screening |
|
Risk calculators and risk factors for Peutz-Jeghers syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Screening for cancerous lesions by small intestine radiography, esophagogastroduodenoscopy (EGD), colonoscopy, pancreatic ultrasound, pelvic ultrasound, mammography, and Papanicolaou (Pap) test are recommended among patients with Peutz-Jeghers syndrome.
Screening
Patients who are at risk of developing Peutz-Jeghers syndrome are screened for the locations of the hamartomas by:
Screening for cancerous lesions include the following:
- Small intestine radiography (every 2 years)
- Esophagogastroduodenoscopy (every 2 years)
- Colonoscopy every 2 years
- Pancreatic ultrasound (annually)
- Endoscopic ultrasound
- Magnetic resonance cholangiopancreatography (MRCP)
- Abdominal CT
- Pelvic ultrasound (annually)
- Testicular ultrasound (annually)
- Mammography at ages 25, 30, 35, and 38 years, then every 2 years until age 50 years, then annually
- Cervical Papanicolaou (Pap) test (annually).
- Annual physical examination that includes evaluation of the breasts, abdomen, pelvis, and testes should be done by a physician
- Annual complete blood count to check for anemia should be done